SCHEMBL3788927

SCHEMBL3788927

CC(C)N1CCN(c2nc(NCc3ccccc3)nc3nnc(-c4ccc(F)cc4)nc23)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.44
HRH4 Q9H3N8 4/20 0.41
HRH1 P35367 3/20 0.41
PDE4A P27815 4/20 0.41
PDE4B Q07343 4/20 0.41
PDE4C Q08493 4/20 0.41
PDE4D Q08499 4/20 0.41
TSHR P16473 3/20 0.39
HSD17B10 Q99714 3/20 0.39
F2 P00734 2/20 0.39
USP2 O75604 1/20 0.39
KMT2A Q03164 1/20 0.39
TLR9 Q9NR96 3/20 0.39
TLR7 Q9NYK1 3/20 0.39
TP53 P04637 2/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3704626 0.90 HRH4 (0.52) ACHEHRH4HRH1PDE4APDE4B
SCHEMBL3788257 0.88 TLR9 (0.44) ACHEHRH4HRH1PDE4APDE4B
SCHEMBL3786031 0.86 CNR2 (0.42) HRH4HRH1HSD17B10KMT2ATLR9
SCHEMBL3779641 0.86 HTT (0.50) ACHEPDE4APDE4BPDE4CPDE4D
SCHEMBL3785003 0.86 PDE4A (0.47) ACHEHRH4HRH1PDE4APDE4B
SCHEMBL3784610 0.85 PDE4A (0.50) ACHEHRH4HRH1PDE4APDE4B
SCHEMBL3784136 0.85 PDE4A (0.44) HRH4HRH1PDE4APDE4BPDE4C
SCHEMBL3781010 0.84 HRH4 (0.52) HRH4HRH1PDE4APDE4BPDE4C
SCHEMBL3786948 0.84 PDE4A (0.43) HRH4HRH1PDE4APDE4BPDE4C
SCHEMBL3783454 0.83 ACHE (0.47) ACHEHRH4HRH1PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010083645-A1 PYRIMIDO[5,4-e][1,2,4]TRIAZINES AND USES THEREOF SHANGHAI TARGETDRUG CO., LTD (CN) 2010-07-29 WO disclosed